May 2011
Synthesis and Fungicidal Activity of 1,3-Thiazoline Derivatives Bearing Nitrophenyl
Group on the 2-Position
731
163.87. IR (cmꢁ1): 2955, 1593, 1522, 1347, 1007, 858, 690.
Anal. Calcd for C13H16N2O2S (264.35): C 59.07, H 6.10, N
10.60. Found: C 59.35, H 6.25, N 10.45.
method, their fungicidal activity against eight agrocul-
tural fungi were evaluated. The 2-(p-, m-)nitrophenylth-
iazoline with 4-iso-propyl group displayed good fungici-
dal activities against two agrocultural fungi compared
with commercial fungicide chlorothalonil.
4d. Mp: 116–117ꢀC. 1H-NMR (300 MHz, CDCl3): d 8.24–
8.27 (m, 2H, ArH), 7.97–8.02 (m, 2H, ArH), 7.24–7.37 (m,
5H, ArH), 4.93–5.03 (m, 1H, CHN¼¼), 3.42 (dd, J ¼ 8.35,
11.14 Hz, 1H), 3.20–3.34 (m, 2H, CH2), 2.88 (dd, J ¼ 8.73,
13.63 Hz,1H). 13C-NMR (75 MHz, CDCl3): d 37.84, 40.16,
78.98, 123.58, 126.61, 128.55, 129.18, 129.25, 138.02, 138.76,
149.22, 165.28. IR (cmꢁ1): 2930, 1510, 1495, 1336, 1230,
1108, 740. Anal. Calcd for C16H14N2O2S (298.369): C 64.41,
H 4.73, N 9.39. Found: C 64.55, H 4.88, N 9.43.
EXPERIMENTAL
NMR spectra were recorded on a Bruker Avance DPX300
spectrometer with tetramethylsilane as internal standard and
CDCl3 as solvent. Infrared spectra were obtained on a Nicolet
AVATAR 330 FTIR spectrometer. Elemental analyses were
carried out on an Elementar Vario EL instrument. Melting
points were measured on an XT-4 melting point apparatus and
were uncorrected. Solvents were purified and dried following
standard procedures.
1
4e. Mp: 85.0–86.0ꢀC. H-NMR (300 MHz, CDCl3): d 8.27–
8.32 (m, 2H, ArH), 8.07–8.11 (m, 2H, ArH), 7.33–7.42 (m,
5H, ArH), 5.76 (t, J ¼ 9.33 Hz, 1H, CHN¼¼), 3.90 (dd, J ¼
8.85, 11.06 Hz, 1H), 3.42 (dd, J ¼ 9.81, 11.05 Hz, 1H); 13C-
NMR (75 MHz, CDCl3): d 41.72, 81.55, 124.46, 127.39,
128.80, 129.67, 130.21, 139.58, 142.20, 150.36, 167.58. IR
(cmꢁ1): 1593, 1521, 1349, 1026, 851, 754, 690. Anal. Calcd
for C15H12N2O2S (284.342): C 63.36, H 4.25, N 9.85. Found:
C 63.36, H 4.36, N 9.69.
5a. Mp: 49.0–50.0ꢀC. 1H-NMR (300 MHz,CDCl3): d 8.67
(t, J ¼ 1.92 Hz, 1H, ArH), 8.28–8.33 (m, 1H, ArH), 8.12–8.16
(m, 1H, ArH), 7.57–7.62 (m, 1H, ArH), 4.77–4.84 (m, 1H,
CHN¼¼), 3.62 (dd, J ¼ 10.88, 8.28 Hz, 1H), 3.13 (dd, J ¼
10.88, 7.77 Hz, 1H), 1.49 (d, J ¼ 6.72 Hz, 3H, CH3). 13C-
NMR (75 MHz, CDCl3): d 20.3, 40.5, 73.1, 123.2, 125.4,
129.4, 133.9, 135.0, 148.2, 164.3. IR (cmꢁ1): 2981, 1567,
1517, 1345, 1110, 960, 836, 681. Anal. Calcd for
C10H10N2O2S (222.271): C 54.04, H 4.54, N 12.60. Found: C
54.28, H 4.50, N 12.69.
General procedure for the synthesis of thiazoline 4a–e,
5a–e. The p- or m-nitrobenzoic acid (0.5 g, 2.99 mmol) was
refluxed with SOCl2 (3.0 mL) for 12 h, then the excess SOCl2
was removed in vacuo. Benzene (5 mL) was added and
removed again to dryness to remove the trace amount of
SOCl2 and afforded the acyl chloride. The acyl chloride in
CH2Cl2 (15 mL) was added dropwise to a solution of amino
alcohol (3.10 mmol) and Et3N (2 mL, 14.5 mmol) in CH2Cl2
(15 mL) at 0ꢀC and stirred at room temperature for 4–6 h. The
reaction mixture was evaporated to remove the solvent in
vacuo, and toluene (20 mL) and Et3N (4 mL, 28.9 mmol)
were added to the crude hydroxyl amide, P2S5 (1.0 g, 4.5
mmol) was added under refluxing in three portions within 1 h,
and the suspension was continued to reflux for another 4–6 h.
After being cooled to room temperature, the solution was
washed with H2O (5 mL ꢂ 2), dried over anhydrous Na2SO4,
and concentrated to give the crude product. Column chromato-
graphic purification on silica gel (V/V, ethyl acetate/petroleum
ether, 1:5) afforded the thiazoline compounds 4a–e and 5a–e.
5b. Mp: 53.5–54.5ꢀC. 1H-NMR (300 MHz, CDCl3): d 8.64
(t, J ¼ 1.85 Hz, 1H, ArH), 8.28 (dd, J ¼ 1.32, 8.21 Hz, 1H,
ArH), 8.12 (d, J ¼ 8.85 Hz, 1H, ArH), 7.59 (t, J ¼ 7.76 Hz,
1H, ArH), 4.41–4.49 (m, 1H, CHN¼¼), 3.49 (dd, J ¼ 8.80,
10.92 Hz, 1H), 3.22 (t, J ¼ 9.88 Hz, 1H), 2.04–2.15 (m, 1H,
CH), 1.13 (d, J ¼ 6.75 Hz, 3H, CH3), 1.03 (t, J ¼ 6.75 Hz,
3H, CH3). 13C-NMR (75 MHz, CDCl3): d 18.87, 19.50, 33.07,
35.87, 84.08, 122.72, 124.99, 129.17, 133.72, 134.82, 147.89,
163.52. IR (cmꢁ1): 2985, 1603, 1565, 1009, 947, 785, 697.
Anal. Calcd for C12H14N2O2S (250.325): C 57.58, H 5.64, N
11.19. Found: C 57.45, H 5.66, N 11.07.
1
4a. Mp: 57.0–58.0ꢀC. H-NMR (300 MHz, CDCl3): d 8.24–
8.28 (m, 2H, ArH), 7.97–8.01 (m, 2H, ArH), 4.77–4.85 (m,
1H, CHN¼¼), 3.62 (dd, J ¼ 8.34, 10.86 Hz, 1H), 3.13 (dd, J ¼
7.86, 10.89 Hz, 1H), 1.49 (d, J ¼ 6.72 Hz, 3H, CH3); 13C-
NMR (75 MHz, CDCl3): d 20.23, 40.43, 73.31, 77.2, 123.57,
129.18, 138.88, 149.20, 164.51. IR (cmꢁ1): 1588, 1519, 1361,
1317, 1110, 965, 860, 690. Anal. Calcd for C10H10N2O2S
(222.271): C 54.04, H 4.54, N 12.60. Found: C 54.25, H 4.25,
N 12.64.
1
5c. H-NMR (300 MHz, CDCl3): d 8.78 (t, J ¼ 1.89 Hz,
1H, ArH), 8.31–8.35 (m, 1H, ArH), 8.26–8.34 (m, 2H, ArH),
7.57–7.62 (m, 1H, ArH), 4.57 (dd, J ¼ 8.07, 9.39 Hz, 1H),
4.33–4.44 (m, 1H, CHN¼¼), 4.05 (t, J ¼ 8.04 Hz, 1H), 1.81–
1.90 (m, 1H, CH2), 1.67–1.76 (m, 1H, CH2), 1.36–1.45 (m,
1H, CH, 0.95–1.05 (m, 6H, CH3). 13C-NMR (75 MHz,
CDCl3): d 22.72, 22.76, 25.50, 45.48, 65.48, 73.65, 123.28,
125.64, 129.37, 129.85, 133.93, 148.23, 161.26. IR (cmꢁ1):
2982, 1536, 1349, 838, 758, 714, 681. Anal. Calcd for
C13H16N2O2S (264.35): C 59.07, H 6.10, N 10.60. Found: C
59.38, H 6.05, N 10.84.
4b. Mp: 49–51ꢀC. 1H-NMR (300 MHz, CDCl3): d 8.23–
8.28 (m, 2H, ArH), 7.97–8.01 (m, 2H, ArH), 4.43–4.51 (m,
1H, CHN¼¼), 3.49 (dd, J ¼ 8.82, 10.95 Hz, 1H), 3.22 (dd, J ¼
9.75, 10.95 Hz, 1H), 2.06–2.17 (m, 1H, CH), 1.13 (d, J ¼
6.75 Hz, 3H, CH3), 1.04 (d, J ¼ 6.75 Hz, 3H, CH3). 13C-NMR
(75 MHz, CDCl3): d 19.07, 19.71, 33.30, 36.06, 84.49, 123.55,
129.16, 139.01, 149.14, 164.16. IR (cmꢁ1): 2955, 1604, 1578,
1012, 785, 747, 697. Anal. Calcd for C12H14N2O2S (250.325):
C 57.58, H 5.64, N 11.19. Found: C 57.45, H 5.45, N 11.44.
5d. Mp: 56.0–57.0ꢀC. 1H-NMR (300 MHz, CDCl3): d 8.67
(t, J ¼ 1.89 Hz, 1H, ArH), 8.29–8.33 (m, 1H, ArH), 8.17–8.31
(m, 1H, ArH), 7.60 (t, J ¼ 7.83 Hz, 1H, ArH), 7.23–7.34 (m,
5H, ArH), 4.94–4.99 (m, 1H, CHN¼¼), 3.42 (dd, J ¼ 11.13,
8.31 Hz, 1H), 3.21–3.34 (m, 2H, CH2), 2.87 (dd, J ¼ 8.85,
16.80 Hz, 1H). 13C-NMR (75 MHz, CDCl3): d 37.85, 40.16,
78.82, 123.21, 125.52, 126.53, 129.27, 129.47, 133.94, 134.92,
138.06, 148.25, 165.17. IR: 1602, 1530, 1347, 1246, 725, 682.
1
4c. Mp: 38.5–39.5ꢀC. H-NMR (300 MHz, CDCl3): d 8.22–
8.27 (m, 2H, ArH), 7.95–8.00 (m, 2H, ArH), 4.68–4.78 (m,
1H, CHN¼¼), 3.75 (dd, J ¼ 8.35, 10.85 Hz,1H), 3.12 (dd, J ¼
8.39, 10.86 Hz, 1H), 1.78–1.96 (m, 2H, CH2), 1.47–1.56 (m,
1H, CH), 1.04 (d, J ¼ 6.49 Hz, 3H, CH3), 1.01 (d, J ¼ 6.18
Hz, 3H, CH3). 13C-NMR (75 MHz, CDCl3): d 22.51, 22.66,
25.80, 38.99, 44.04, 76.37, 123.39, 129.03, 138.84, 149.97,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet